These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38474)

  • 1. Antagonism of apomorphine-induced hyperthermia in MAOI-pretreated rabbits as a sensitive model of neuroleptic activity.
    Fjalland B
    Psychopharmacology (Berl); 1979 May; 63(2):119-23. PubMed ID: 38474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic influence on hyperthermia induced by 5-hydroxytryptophan and p-methoxy-amphetamine in MAOI-pretreated rabbits.
    Fjalland B
    Psychopharmacology (Berl); 1979 May; 63(2):113-7. PubMed ID: 38473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
    Quock RM; Horita A
    Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine: modification of its hyperthermic effect in rabbits by p-chlorophenylalanine.
    Quock RM; Horita A
    Science; 1974 Feb; 183(4124):539-40. PubMed ID: 4272136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways.
    Carmo H; Remião F; Carvalho F; Fernandes E; de Boer D; dos Reys LA; de Lourdes Bastos M
    Toxicol Appl Pharmacol; 2003 Aug; 190(3):262-71. PubMed ID: 12902197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties.
    Christensen AV; Fjalland B; Pedersen V; Danneskiold-Samsoe P; Svendsen O
    Eur J Pharmacol; 1977 Jan; 41(2):153-62. PubMed ID: 12988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies on the antagonism by antidepressants of the hypothermia induced by apomorphine.
    Menon MK; Vivonia CA; Kling AS
    Neuropharmacology; 1984 Feb; 23(2A):121-7. PubMed ID: 6325987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penfluridol blockade of apomorphine: dependence of duration on species and endpoint.
    Weissman A
    Eur J Pharmacol; 1975; 33(2):267-75. PubMed ID: 1237408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of apomorphine and stressors in the production of hyperthermia in the rabbit.
    Snow AE; Horita A
    J Pharmacol Exp Ther; 1982 Feb; 220(2):335-9. PubMed ID: 7199085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of responses to novelty by apomorphine and its antagonism by neuroleptics in mice.
    Misslin R; Ropartz P; Jung L
    Psychopharmacology (Berl); 1984; 82(1-2):113-7. PubMed ID: 6141583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; el-Hady KA; Watanabe H
    Pharmacol Biochem Behav; 1995 Oct; 52(2):379-84. PubMed ID: 8577805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
    Van Ree JM; Caffé AR; Wolterink G
    Neuropharmacology; 1982 Nov; 21(11):1111-7. PubMed ID: 6184640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation.
    Megens AA; Hendrickx HM; Lavreysen H; Langlois X
    J Pharmacol Exp Ther; 2013 Dec; 347(3):681-96. PubMed ID: 24071734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.